A light in the darkness: sodium fluorescein-assisted peripheral nerve sheath tumors resection – a comprehensive systematic review and single-arm meta-analysis

• Published in: Neurosurgical review Vol. 47; no. 1; p. 181
• Main Authors: Verly, Gabriel, Delfino, Thiffany, Oliveira, Leonardo de Barros, Batista, Sávio, Sousa, Marcelo Porto, Schevz, Rodrigo, Ferreira, Marcio Yuri, Bertani, Raphael
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 23-04-2024
• Subjects: Fluorescein; Fluorescent Dyes; Humans; Medicine; Medicine & Public Health; Nerve Sheath Neoplasms - surgery; Neurosurgery; Neurosurgical Procedures - methods; Review; Peripheral nerve; Tumor; Resection; Neurosurgery; Fluorescein; Schwannoma
• ISSN: 1437-2320; 1437-2320
• DOI: 10.1007/s10143-024-02414-z

The treatment for peripheral nerve sheath tumors (PNSTs) is based on surgical excision and the primary goal is to improve symptoms whilst preserving neurological function. In order to improve this technique, surgeons may use sodium fluorescein (SF) to help visualize the neoplasm and, consequently, facilitate its removal. Aiming to assess the efficacy of this emerging surgical strategy, we conducted a systematic review and single-arm meta-analysis. We conducted a systematic search on the
PubMed
,
Embase
, and
Web of Science
databases, following the
PRISMA
guidelines. Studies without outcomes of interest, case series with less than four patients, letters, comments, technical notes, editorials, reviews, and basic research papers were excluded. The outcomes considered for this study were: the number of tumors that achieved total resection, subtotal resection, or near total resection, the approach/technique utilized by the surgeon, SF-related complications, and total complications. Five studies, with a total of 175 individuals, were included in our survey. Notably, 70% of the neoplasms presented by the patients were schwannomas. Considering extracranial lesions, we found a proportion of 96% (95% CI: 88 − 100%) in total resection, 0% (95% CI: 0–1%) in near total resection, and 4% (95% CI: 0–12%) in subtotal resection, all linked to an amount of 185 analyzed PNSTs. Furthermore, a proportion of 1% (95% CI: 0 − 2%) in SF-related complications was spotted among 183 patients. Finally, total complications analysis accounted for 11% (95% CI: 0 − 25%) among 183 individuals. We concluded that SF-assisted resection of PNSTs is a suitable and relatively safe technique, linked to minimum complications, of which the majority was not associated with the chemical compound itself. Future research is necessary to increase the number of patients available in the current literature and, therefore, enhance future analyses.